Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Dexmedetomidine for POCD in Cataract Surgery
NCT04730596Completed
- Sponsor
- Tanta University
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Placebo, Ketamine and Dexmedetomidine (3 arms). Primary endpoint: Incidence of Postoperative Cognitive Dysfunction at 3 days. Started Feb 2021; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT04730596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730596.